3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Fallopian Tube Neoplasms
4
Ovarian Neoplasms
3
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Solitary Fibrous Tumor, Pleural
1
Small Cell Lung Carcinoma
1
Sarcoma, Alveolar Soft Part
1
Prostatic Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Melanoma
1
Leiomyosarcoma
1
Glioblastoma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Colorectal Neoplasms
1
Carcinosarcoma
1
Carcinoma, Endometrioid
1
Interventions
pembrolizumab
14
Nivolumab
11
Ipilimumab
10
cabozantinib
6
Axitinib
6
belzutifan
5
Radiosurgery
5
atezolizumab
4
Sunitinib
4
palbociclib
3
lenvatinib
3
Surveys and Questionnaires
3
Radiotherapy
3
Pluvicto
3
Everolimus
3
Blood Specimen Collection
3
Biopsy
3
zimberelimab
2
pazopanib
2
cemiplimab
2
Therapeutics
2
Methods
2
Magnetic Resonance Spectroscopy
2
Irinotecan
2
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
2
trebananib
1
toripalimab
1
tocilizumab
1
temsirolimus
1
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
cediranib
×
1 year
×
Clear all
No trials found.